Shawky, Heba https://orcid.org/0000-0001-8403-1143
Tabll, Ashraf A. https://orcid.org/0000-0001-7041-5445
Elshenawy, Reem M. https://orcid.org/0000-0001-7861-238X
Helmy, Naiera M. https://orcid.org/0000-0003-3788-3372
Moustafa, Rehab I. https://orcid.org/0000-0002-8277-8304
Elesnawy, Yasser K. https://orcid.org/0000-0002-9863-5551
Abdelghany, Marwa M. https://orcid.org/0000-0001-7046-9494
El-Abd, Yasmine S. https://orcid.org/0000-0002-8212-6146
Funding for this research was provided by:
National Research Centre (12010130)
National Research Centre Egypt
Article History
Received: 10 November 2023
Accepted: 4 January 2024
First Online: 18 January 2024
Change Date: 22 December 2024
Change Type: Update
Change Details: The affiliation of the authors Yasser K. Elesnawy4, Marwa M. Abdelghany3 have been updated.
Change Date: 23 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12934-024-02622-8
Declarations
:
: This study followed STARD 2015 reporting guidelines, and it was conducted following the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The collection of human sera was approved by the Medical Ethical Committee of the National Research Centre (Approval NO: 19314).The consent for participation/publication is not applicable in this study, as human sera were collected in the context of the National Campaign for HCV Screening and Treatment (<i>100-Million Seha</i> initiative) in Egypt during the period 2018–2022, supervised by the National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population, Cairo, Egypt.
: In this article, data have been used with the permission of the relevant authorities. The privacy and confidentiality of the obtained data were ensured for all participants.
: The authors declare that they have no competing interests.